GoHealth Earnings Preview
GoHealth (NASDAQ: GOCO) is set to announce its quarterly earnings on March 14, 2024. Analysts are projecting an EPS of $2.72 for the company. Investors are eagerly awaiting to see if GoHealth will exceed this estimate and provide optimistic guidance for the next quarter, as guidance tends to have a greater impact on stock prices than earnings surprises.
Performance Analysis
In the previous quarter, GoHealth outperformed EPS expectations by $0.29, resulting in a 3.18% increase in share price the following day. Here is a snapshot of GoHealth’s historical performance and the corresponding price fluctuations:
Q3 2023
EPS Estimate: -2.90
EPS Actual: -2.61
Price Change %: 3.0%
Q2 2023
EPS Estimate: -2.92
EPS Actual: -3.27
Price Change %: 2.0%
Q1 2023
EPS Estimate: -1.96
EPS Actual: -1.12
Price Change %: 0.0%
Q4 2022
EPS Estimate: 1.33
EPS Actual: -7
Price Change %: -24.0%
Stock Analysis
As of March 12, GoHealth shares were trading at $13.16, marking a 25.2% decline over the past year. With this downward trend, long-term investors may be approaching the upcoming earnings announcement with a pessimistic viewpoint.
For more comprehensive insights on GoHealth’s earnings and performance, you can check out their earnings calendar on their official website.
GOCO Stock Performance Analysis: March 13, 2024
On March 13, 2024, GOCO stock had a mixed performance as it traded in the middle of its 52-week range and below its 200-day simple moving average. The stock opened at $13.27, which was $0.11 higher than its previous close. However, throughout the trading day, the price of GOCO shares decreased by $0.16, resulting in a 1.22% drop by the time the market closed.
This price movement suggests that there was some volatility in the stock on that particular day. Investors may have been reacting to various factors such as market conditions, company news, or broader economic trends. The fact that GOCO was trading below its 200-day simple moving average could indicate that the stock may be facing some downward pressure in the longer term.
It’s important for investors to carefully analyze stock performance and consider various factors before making any investment decisions. While one day of trading does not necessarily indicate a long-term trend, it can provide valuable insights into market sentiment and potential opportunities for investors.
Overall, the performance of GOCO stock on March 13, 2024, was mixed with an initial uptick in the opening price followed by a decline throughout the trading day. Investors should continue to monitor the stock’s performance and stay informed about any developments that may impact its price in the future.
GOCO Stock Analysis: Resilient Growth in Net Income and EPS Despite Revenue Decrease
On March 13, 2024, GOCO stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $631.67 million, which decreased by 40.54% compared to the previous year. In the third quarter, the total revenue was $132.04 million, showing a decrease of 7.52% compared to the previous quarter.
Despite the decrease in total revenue, GOCO managed to increase its net income over the past year. The net income for the year was -$148.71 million, which represents a 21.47% increase compared to the previous year. In the third quarter, the net income was -$23.91 million, showing a 17.39% increase compared to the previous quarter.
Earnings per share (EPS) also showed improvement for GOCO stock. The EPS for the year was -$17.61, which increased by 34.29% compared to the previous year. In the third quarter, the EPS was -$2.61, showing a 20.08% increase compared to the previous quarter.
Overall, GOCO stock demonstrated resilience and growth in its financial performance despite the challenges faced in the market. Investors may find GOCO stock to be a promising investment opportunity based on the company’s ability to increase net income and EPS, despite the decrease in total revenue.
